To Survive After ICU Discharge

In-Hospital Mortality Clinical Trial

Official title:

Multicenter Prospective Study: To Survive After ICU Discharge

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02599636
• Other study ID #: Althaia
• Status: Active, not recruiting
• Phase: N/A
• First received: October 30, 2015
• Last updated: July 13, 2016
• Start date: October 2015
• Est. completion date: September 2016

Study information

• Verified date: July 2016
• Source: Althaia Xarxa Assistencial Universitària de Manresa
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Comité Ético de Investigación Clínica
• Study type: Observational

Clinical Trial Summary

Many factors before and after ICU stay determine the outcome of patients at ICU discharge, the type of illness, physical dependence and other sequelae can be a trigger for complications in hospital ward which can induce ICU readmission and worse outcome. The quality of medical assistance during all the hospitalisation should be guaranteed and many complications or fatal events could be avoidable.

The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.

Description:

Material and Methods This observational multicenter study will be done in 21 medical-surgical ICUs. We will use Sabadell Score like prognostic scale at ICU discharge and the intensivist will collaborate with the medical team in medical assistance of patients at risk (Sabadell Score 1 and 2). Investigators will compare the hospital mortality and the readmission rate with a previous period when this collaboration didn't exist.

Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1200
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• All patients with Sabadell Score 1 (poor prognosis in long term) and 2 (poor prognosis in short term) at ICU discharge

Exclusion Criteria:

• patients younger than 18 years old

• patients with Sabadell Score 0 (good prognosis)

• patients with Sabadell Score 3 (null expected survival)

• patients transferred to other hospitals

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• In-Hospital Mortality
• Number of ICU Readmission
• Number of Warnings On-duty

Intervention

Other:
• None intervention
Investigators will study the usual medical assistance

Locations

Country	Name	City	State
Spain	Althaia Xarxa Assistencial Universitaria de Manresa	Manresa	Barcelona

Sponsors (1)

Lead Sponsor	Collaborator
Althaia Xarxa Assistencial Universitària de Manresa

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The decline in hospital mortality		3 months	Yes
Secondary	The decline in number of warnings on-duty		3 months	Yes